HIV-related mortality in sub-Saharan Africa remains high, partly due to challenges with monitoring and intervening on patients presenting with advanced disease. Mobile health technologies, including biosensors and cellular phone platforms, among others, hold great promise to improve monitoring, communication and targeting of interventions to at-risk people living with HIV/AIDS (PLWHA). Yet, the majority of these technologies are not implemented due to inadequate attention to behavioral aspects of the human- technology interface. The Consortium for Affordable Medical Technologies (CAMTech), based at the Massachusetts General Hospital, is developing a robust portfolio of technologies for improving healthcare in resource limited settings (RLS). I will derive and validate a behavioral science framework of technology acceptance for novel, patient-centered technologies in RLS by evaluating 1 device in the CAMTech portfolio, a wireless biosensor for remote detection of abnormal vital signs. My overarching goal is to become a leader in the study of acceptance and implementation of low-cost medical technologies to improve healthcare delivery in RLS, using a foundation in behavioral theory to evaluate and address barriers to technology acceptance. To achieve independence, I require further training in: 1) qualitative research methods to derive a technology acceptance theoretical framework for patient-centered interventions in RLS; 2) behavioral theory and analysis methods focused on developing and testing technology acceptance frameworks in RLS; and 3) aspects of technology evaluation, including clinical research methods and technical elements of devices, to evaluate technology acceptance and communicate results with engineers. My mentoring team includes Dr. David Bangsberg, an expert in behavioral aspects of HIV treatment who leads CAMTech, and experts in qualitative methods (Ware), behavioral theory and technology acceptance (Safren, Venkatesh), technology design and implementation (Fletcher, Remien), and clinical study design and analysis in RLS (Lockman, Mulogo, Petersen). With their guidance, I will test my central hypothesis that behavioral theory can optimize the evaluation of novel technologies in RLS, through the following specific aims: 1) develop a technology acceptance model relevant to PLWHA in RLS using qualitative research methods; 2) derive and test scales to measure constructs in the emergent model from Aim 1; and 3) using the framework derived in Aims 1 and 2, perform a pilot study of acceptability and feasibility of the biosensor to identify abnormal vitl signs in at-risk PLWHA. The research plan is innovative because it will derive and test a framework applicable to the multitude of promising low-cost technologies to improve healthcare delivery in RLS. Further, it will position me to apply for an NIH R01 to test the efficacy of this and other devices. I am well positioned to accomplish these aims based upon my success conducting research in Uganda, strong mentoring team, and institutional support both in the United States and Uganda.

Public Health Relevance

The current paradigm of HIV care in RLS does not optimally monitor patients or target interventions to those at risk of poor outcomes. Mobile health (mHealth) technologies, which are designed to strategically locate and deliver right-place, right-time interventions to the patients most in need, have been thwarted by a failure to evaluate behavioral aspects of their use in target populations. The proposed research is highly relevant to public health because it will leverage behavioral theory to evaluate and advance a public health paradigm, which will enable the delivery of interventions to high-risk PLWHA when and where they are most in need. These aims are closely aligned with trans-NIH goals to improve disease outcomes for PLWHA and to reduce HIV-related disparities in care.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
4K23MH099916-04
Application #
9093839
Study Section
Behavioral and Social Consequences of HIV/AIDS Study Section (BSCH)
Program Officer
Stirratt, Michael J
Project Start
2013-07-12
Project End
2018-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
4
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Siedner, Mark J; Baisley, Kathy; Orne-Gliemann, Joanna et al. (2018) Linkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort study. BMJ Open 8:e023369
Boyce, Ross; Reyes, Raquel; Keeler, Corinna et al. (2018) Anemia was an Uncommon Complication of Severe Malaria in a High-Transmission Rural Area of Western Uganda. Am J Trop Med Hyg 98:683-691
Boyce, Ross M; Hathaway, Nick; Fulton, Travis et al. (2018) Reuse of malaria rapid diagnostic tests for amplicon deep sequencing to estimate Plasmodium falciparum transmission intensity in western Uganda. Sci Rep 8:10159
Bilounga Ndongo, Chanceline; Eteki, Lucrèce; Siedner, Mark et al. (2018) Prevalence and vaccination coverage of Hepatitis B among healthcare workers in Cameroon: A national seroprevalence survey. J Viral Hepat 25:1582-1587
White, Emily E; Downey, Jordan; Sathananthan, Vidiya et al. (2018) A Community Health Worker Intervention to Increase Childhood Disease Treatment Coverage in Rural Liberia: A Controlled Before-and-After Evaluation. Am J Public Health 108:1252-1259
Abdallah, Amir; Chang, Jonathan L; O'Carroll, Cumara B et al. (2018) Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review. J Stroke Cerebrovasc Dis 27:1828-1836
North, Crystal M; Muyanja, Daniel; Kakuhikire, Bernard et al. (2018) Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda. J Acquir Immune Defic Syndr 78:543-548
Mitton, Julian A; North, Crystal M; Muyanja, Daniel et al. (2018) Smoking cessation after engagement in HIV care in rural Uganda. AIDS Care 30:1622-1629
Siedner, Mark J; Triant, Virginia (2018) Undetectable = Untransmittable and Your Health: The personal benefits of early and continuous therapy for HIV infection. J Infect Dis :
Boum Ii, Yap; Burns, Bridget F; Siedner, Mark et al. (2018) Advancing equitable global health research partnerships in Africa. BMJ Glob Health 3:e000868

Showing the most recent 10 out of 100 publications